NCT07074678

Brief Summary

The goal of this study is to determine the extent to which neuroimaging metrics (e.g., functional MRI) are associated with the current level of consciousness, and future consciousness recovery, in patients with disorders of consciousness resulting from acute brain injury. The main questions this study aims to answer are: How do functional MRI findings (e.g., covert consciousness and network connectivity) associate with current level of consciousness? How do functional MRI findings (e.g., covert consciousness and network connectivity) associate with future recovery of consciousness? How does noxious stimulation affect the detection of covert consciousness and functional brain network connectivity?

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
34mo left

Started Mar 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress53%
Mar 2023Mar 2029

Study Start

First participant enrolled

March 8, 2023

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

May 22, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 20, 2025

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 8, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 8, 2029

Last Updated

July 20, 2025

Status Verified

July 1, 2025

Enrollment Period

5 years

First QC Date

May 22, 2025

Last Update Submit

July 16, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Detection of technologic covert consciousness

    Brain activity during the delivery of commands, as compared to brain activity during rest, will be measured during the functional MRI scan. Brain activity that is significantly more associated with commands and that occurs in the premotor cortex or supplementary motor area will be interpreted as evidence of technologic covert consciousness.

    Baseline, during hospitalization (estimated approximately 1 month from brain injury)

  • Functional network connectivity

    Functional connectivity of brain networks will be measured during a resting state functional MRI sequence without noxious stimulation. Another sequence may be obtained during noxious stimulation.

    Baseline, during hospitalization (estimated approximately 1 month from brain injury)

  • Detection of behavioral covert consciousness

    The Coma Recovery Scale - Revised (CRS-R) will be used to assess the presence of behavioral covert consciousness, defined as the minimally conscious state minus (non-language based, but purposeful, behaviors), or the minimally conscious state plus (command-following, intelligible verbalization, and intentional communication). Higher scores (maximum 23) reflect higher levels of consciousness than lower scores (minimum 0).

    Baseline, during hospitalization (estimated approximately 1 month from brain injury), within 24 hours of the functional MRI

  • Overt consciousness recovery based on Disability Rating Scale

    Overt consciousness, defined as command-following as measured with the Disability Rating Scale, will be evaluated at hospital discharge, and 3 and 6 months afterwards.

    Through study completion: At hospital discharge (estimated approximately 1 month from brain injury), 3 months after hospital discharge, and 6 months after hospital discharge

Study Arms (1)

Single arm

EXPERIMENTAL

Patients and healthy controls will undergo functional MRI, which may include auditory and noxious stimulation.

Diagnostic Test: Functional MRI (fMRI)

Interventions

Functional MRI (fMRI)DIAGNOSTIC_TEST

Research MRI, which will include both structural and functional sequences, will either be collected independently, or in conjunction with clinically-indicated sequences. Functional MRI captures the blood oxygen level dependent (BOLD) signal that reflects brain activity. A subset of the PREDICT study fMRI will include sequences with auditory and/or noxious stimulation. Noxious stimulation will be delivered with an MRI-compatible device that delivers intermittent nailbed pressure under computerized control. Additionally, the BOLD signal will be captured at rest to investigate functional neural networks.

Single arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Acute brain injury (including, but not limited to ischemic stroke, intracranial hemorrhage, anoxic brain injury, traumatic brain injury, or encephalitis)
  • Inability to follow commands due to a disorder of consciousness (comatose, vegetative, or minimally conscious state) caused by the underlying brain injury
  • Age 18 or greater
  • Enrolled within 28 days of brain injury

You may not qualify if:

  • Imminent death (as indicated, for example, by planned transition to palliative measures, brain death testing, or severe medical instability)
  • MRI contraindications would exclude patients from imaging component of study
  • For healthy controls:
  • MRI contraindications
  • History of brain injury to neurological disease
  • History of diabetes, high blood pressure, kidney disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

MeSH Terms

Conditions

Consciousness DisordersComaPersistent Vegetative State

Interventions

Magnetic Resonance Imaging

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental DisordersUnconsciousnessBrain Damage, ChronicBrain DiseasesCentral Nervous System Diseases

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • David J Fischer, MD

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 22, 2025

First Posted

July 20, 2025

Study Start

March 8, 2023

Primary Completion (Estimated)

March 8, 2028

Study Completion (Estimated)

March 8, 2029

Last Updated

July 20, 2025

Record last verified: 2025-07

Locations